Matthew J Matasar, MD, MS¹, Chan Yoon Cheah, MBBS², Dok Hyun Yoon^3*, Sarit E Assouline, MD, MSc⁴, Nancy L. Bartlett, MD^5*, Matthew Ku^6*, Pratyush Giri^7*, Anna Johnston, MBBS (Hons 1), FRACP, FRCPA^8*, Ian W. Flinn, MD, PhD⁹, Andre H. Goy, MD¹⁰, Dimitrios Tzachanis, MD, PhD^11*, Carol O’Hear^12*, Shen Yin¹², Iris To^12*, Kati Sarouei^12*, Chi-Chung Li^12*, Brendan C. Bender^12*, Elicia M. Penuel^12*, Huang Huang^13* and L. Elizabeth Budde¹⁴

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, WA, Australia
³Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Jewish General Hospital, Montreal, QC, Canada
⁵Siteman Cancer Center/Washington University School of Medicine, St. Louis, MO
⁶St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia
⁷Royal Adelaide Hospital, Adelaide, SA, Australia
⁸Royal Hobart Hospital, Hobart, TAS, Australia
⁹Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
¹⁰John Theurer Cancer Center, Hackensack, NJ
¹¹Moores Cancer Center, University of California San Diego, La Jolla, CA
¹²Genentech, Inc., South San Francisco, CA
¹³F. Hoffmann-La Roche Limited, Mississauga, ON, Canada
¹⁴City of Hope National Medical Center, Duarte, CA

Anita Kumar, MD¹, Jason Westin, MD², Stephen J Schuster, MD³, Grzegorz S. Nowakowski, MD⁴, Izidore S. Lossos, MD⁵, Connie Lee Batlevi, MD, PhD⁶, Philip Caron, MD, PhD¹, Pamela Drullinsky, MD^1*, John Gerecitano, MD, PhD⁷, Audrey Hamilton, MD^1*, Paul A. Hamlin, MD⁸, Steven M. Horwitz, MD¹, Allison P. Jacob^9*, Erel Joffe, MD, MSc¹, Ashlee Joseph^6*, Gottfried R. von Keudell, MD, PhD¹, Leana Laraque, BA^6*, Oscar B Lahoud, MD¹⁰, Matthew J Matasar, MD, MS¹¹, Craig H. Moskowitz, MD¹², Chelsea D Mullins, BS^9*, Ariela Noy, MD¹³, Colette Owens, MD¹, Maria Lia Palomba¹, Carol S. Portlock, MD^6*, Ildefonso Rodriguez-Rivera, MD^1*, Gilles Salles, MD, PhD⁶, Venkatraman Seshan, PhD^14*, David J. Straus, MD¹, Shreya Vemuri^15*, Anas Younes, MD¹⁶ and Andrew D Zelenetz, MD, PhD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Mayo Clinic, Rochester, MN
⁵Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷The Janssen Pharmaceutical Companies of Johnson & Johnson, West New York, NJ
⁸David H Koch Center for Cancer Care, Memorial Sloan-Kettering Cancer Ctr., New York, NY
⁹Adaptive Biotechnologies, Seattle, WA
¹⁰Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Brooklyn, NY
¹¹Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY
¹²Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
¹³Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Ctr., New York, NY
¹⁴Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Sloan Kettering Institute, 1275 York Avenue, NY
¹⁶AstraZeneca, New York, NY

Catherine Thieblemont, MD, PhD¹, Maria Gomes da Silva, MD^2*, Olivier Casasnovas, MD^3*, Hervé Ghesquieres, MD, PhD^4*, Gandhi Laurent Damaj, MD, PhD⁵, Judith Trotman, FRACP⁶, Pierre Feugier, MD, PhD^7*, Corinne Haioun, MD PhD⁸, Richard Greil, MD⁹, Dolores Caballero, MD, PhD¹⁰, Armando Lopez-Guillermo¹¹, Sebastian Grosicki, MD, PhD¹², Koen Van Eygen, MD^13*, Sylvia Snauwaert, MD^14*, Ewa Lech-Marańda, MD, PhD^15*, Sonja Heibl, MD^16*, John Catalano, MBBS, FRACP, FRCPA^17*, Amos Cohen, MD¹⁸, Anne Cairoli, MD^19*, Philippe Gaulard, MD, PhD^20*, Franck Morschhauser, MD, PhD^21* and Herve Tilly, MD, PhD²²

¹Department of Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
²Hematology Unit, Portuguese Institue of Oncology, Lisboa, Portugal
³Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
⁴Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
⁵CHU de Caen Normandie, Normandie, France
⁶Concord Hospital, Concord, Australia
⁷Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
⁸Clinical Hematology, Henri Mondor University Hospital, UPEC, Creteil, France
⁹3rd Medical Dept. with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT); Cancer Cluster Salzburg (CCS), Salzburg, Austria
¹⁰Department of Hematology, Hospitalario Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain
¹¹Hematopathology Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Barcelona, Spain
¹²Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
¹³Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium
¹⁴AZ Sint-Jan, Brugge, Belgium
¹⁵Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁶Dept. of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Wels, Austria
¹⁷Frankston Hospital, Frankston, VIC, Australia
¹⁸Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Petah Tikva, Israel
¹⁹Service and Central Laboratory of Hematology, University Hospital Lausanne, CHUV, Lausanne, Switzerland
²⁰Department of Pathology, Henri Mondor Hospital, APHP, Paris Est-Créteil (UPEC) University Faculty, INSERM UMR-S 955, Créteil, France
²¹Department of Hematology, Centre Hospitalier Régional Universitaire De Lille, Lille, France
²²Centre Henri Becquerel, Rouen, France

Julien Depaus^1*, Nina D. Wagner-Johnston², Pier Luigi Zinzani, MD³, Tycel J. Phillips, MD^4*, Joseph Maly, MD⁵, Silvia Ferrari, MD^6*, Emmanuel Bachy, MD, PhD^7*, Locke J. Bryan⁸, Vincent Delwail^9*, Murali Janakiram^10*, Sophie de Guibert^11*, Monica Tani, MD^12*, Jennifer Adeleye^13*, Xiaoyan Zhang^13*, Luqiang Wang^13*, Annette Ervin-Haynes^13* and Carmelo Carlo-Stella, MD¹⁴

¹Department of Hematology, CHU UCL Namur site Godinne, Yvoir, Belgium
²Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
³Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
⁴Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI
⁵Norton Cancer Institute, Louisville, KY
⁶Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⁷Department of Hematology, Hopital Lyon Sud, Pierre-Benite, France
⁸Georgia Cancer Center Augusta University, Augusta, GA
⁹Department of Hematology and Cell Therapy, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
¹⁰Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
¹¹Department of Clinical Hematology, Centre Hospitalier Universitaire de Rennes Hopital Pontchaillou, Rennes, France
¹²Unit of Hematology, Santa Maria delle Croci Hospital, Ravenna, Italy
¹³ADC Therapeutics America, Inc., Murray Hill, NJ
¹⁴Department of Oncology and Hematology, Humanitas Clinical and Research Center - IRCCS, Humanitas University, Rozzano, Italy

Caron A. Jacobson, MD¹, Frederick L. Locke, MD², David B. Miklos, MD, PhD³, Julie M. Vose, MD, MBA⁴, Yi Lin, MD, PhD⁵, Lihua E Budde, MD, PhD⁶, David G. Maloney, MD, PhD⁷, Samantha Jaglowski, MD, MPH⁸, Peter A. Riedell, MD^9*, Lazaros J. Lekakis, MD^10*, Miguel-Angel Perales, MD¹¹, Jenny J. Kim, MD, MS^12*, Jun Kawashima, MD^12*, Yin Yang, MS^12*, John M. Rossi, MS^12*, Lovely Goyal, PhD^12* and Sattva S. Neelapu, MD¹³

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³Stanford University School of Medicine, Stanford, CA
⁴University of Nebraska Medical Center, Omaha, NE
⁵Mayo Clinic, Rochester, MN
⁶City of Hope National Medical Center, Duarte, CA
⁷Fred Hutchinson Cancer Research Center, Seattle, WA
⁸The Ohio State University, Comprehensive Cancer Center, Columbus, OH
⁹The University of Chicago Medical Center, Chicago, IL
¹⁰Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
¹¹Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY
¹²Kite, a Gilead Company, Santa Monica, CA
¹³The University of Texas MD Anderson Cancer Center, Houston, TX

Jessica C. Hochberg, MD^1*, Stanton Goldman, MD^2*, Matthew J. Barth, MD³, Qiuhu Shi, PhD^4*, Liana Klejmont, Pharm D^1*, Lauren Harrison, RN, MSN^1*, Jackie Basso^1*, Yaya Chu, PhD^1*, Humayun Islam^5*, Perry Gerard, MD, MBA, FACR^6*, Javier Oesterheld, MD^7*, Kenneth Matthew Heym, MD^8*, Ivan I. Kirov, MD^9*, Richard A. Drachtman, MD¹⁰, Paul Harker-Murray, MD, PhD¹¹, Sherrie L. Perkins, MD, PhD¹², Rodney R. Miles, MD, PhD¹³, Bruce Shiramizu, MD^14* and Mitchell S Cairo, MD¹

¹Pediatrics, New York Medical College, Valhalla, NY
²Medical City Children's, Dallas, TX
³Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Biostatistics, New York Medical College, Valhalla, NY
⁵New York Medical College, Valhalla, NY
⁶Radiology, New York Medical College, Valhalla
⁷Levine Children's Hosp., Charlotte, NC
⁸Department of Pediatrics, Cook Children's Medical Center, Fort Worth, TX
⁹Children's Hospital of Orange County, Orange, CA
¹⁰Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹¹Children's Hospital of Wisconsin, Milwaukee, WI
¹²ARUP Laboratories, Salt Lake City, UT
¹³Dept. of Pathology and ARUP Institute for Clinical & Experimental Pathology, University of Utah, Salt Lake City, UT
¹⁴University of Hawaii, Honolulu, HI

Patrick M. Reagan, MD¹, Craig A. Portell, MD², Carla Casulo, MD³, Andrea M. Baran, MS^3*, Allison Magnuson, DO^3*, Paul M. Barr, MD⁴, Yelena Lerman, PhD^3*, Krista N French^3* and Jonathan W. Friedberg, MD, MSSc³

¹Wilmot Cancer Institute, University of Rochester Medical Center, Fairport, NY
²Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
³Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁴Wilmot Cancer Institute, Medical Director, Clinical Trial Office, Professor of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

Saad S. Kenderian, MD¹, Olalekan O. Oluwole, MBBS, MPH², Philip L. McCarthy, MD³, Ran Reshef, MD⁴, Parveen Shiraz, MD⁵, Omar Ahmed, PharmD^6*, John Le Gall, MD, MBA^7*, Myrna Nahas, MD^7*, Lily Tang, PhD^7* and Sattva S. Neelapu, MD⁸

¹Department of Immunology, Mayo Clinic, Rochester, MN
²Vanderbilt Univeristy, Nashville, TN
³Roswell Park Cancer Institute, Buffalo, NY
⁴Columbia University Irving Medical Center, New York, NY
⁵Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
⁶Humanigen, Inc., Burlingame, CA
⁷Kite, a Gilead Company, Santa Monica, CA
⁸Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Sarah C. Rutherford, MD¹, John N. Allan, MD¹, Jia Ruan, MD, PhD¹, Richard R. Furman, MD¹, Kristy Richards, MD, PhD^1*, Amelyn Rodriguez, BSN, RN, OCN^1*, Kseniya Gololobova^1*, Arcania Garcia^1*, Leandro Cerchietti, MD¹, Rossella Marullo, MD, PhD², Zhengming Chen, PhD, MPH, MS^1*, Jennifer Santamala, PharmD^1*, Tsiporah B. Shore, MD¹, Adrienne A. Phillips, MD¹, Sebastian Mayer, MD^1*, Jingmei Hsu, MD¹, Usama Gergis, MD¹, Silvia Senese^1*, Trisha Ali-Shaw^1*, Riyaad Rahim^1*, Koen van Besien, MD, PhD¹, John P. Leonard, MD¹ and Peter Martin, FRCPC, MD, MS¹

¹Meyer Cancer Center, Weill Cornell Medicine, New York, NY
²Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

Kathryn Lurain, MD, MPH¹, Ramya Ramaswami, MBBS, MPH^1*, Anaida Widell, RN^1*, Irene Ekwede, RN^1*, Ralph Mangusan, DNP, CRNP^1*, Jomy George, PharmD^2*, Elaine S. Jaffe, MD³, Stefania Pittaluga, MD, PhD³, Maryalice Stetler-Stevenson, MD, PhD^4*, Mark Roth, MD^5*, Constance M. Yuan, MD, PhD^4*, Hao-Wei Wang, MD, PhD⁶, Vickie Ann Marshall^7*, Denise Whitby^8*, Thomas S. Uldrick, MD, MS⁹ and Robert Yarchoan, MD¹

¹HIV/AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD
²Clinical Center, Department of Pharmacy, Clinical Pharmacokinetics Research Laboratory, National Institutes of Health, Bethesda, MD
³Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD
⁵Laboratory of Pathology, National Cancer Institute, Bethesda, MD
⁶Department of Laboratory Medicine, National Cancer Institute, National Institute of Health, Bethesda, MD
⁷Frederick National Laboratory for Cancer Research, Viral Oncology Section, AIDS and Cancer Virus Program, Frederick, MD
⁸Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD
⁹Fred Hutchinson Cancer Research Center, Seattle, WA

Yana Stepanishyna, PhD, MD^1*, Tetiana Skrypets, MD^2*, Olga Novosad, PhD, MD¹, Ian Pastushenko, MD^1* and Irina Kryachok, Professor^1*

¹Oncohematology, National Cancer Institute, Kyiv, Ukraine
²Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy

Yuliya Linhares, MD¹, Mitul D Gandhi², Michael Chung^3*, Jennifer Adeleye^4*, David Ungar⁵ and Mehdi Hamadani, MD⁶

¹Medical Oncology, Miami Cancer Institute, Baptist Health, Miami, FL
²Medical Oncology, Virginia Cancer Specialists, Gainesville, VA
³Hematology/Oncology, The Oncology Institute of Hope and Innovation, Downey, CA
⁴ADC Therapeutics America, Inc., Murray Hill, NJ
⁵Clinical Development, ADC Therapeutics, Murray Hill, NJ
⁶Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Jurriaan Brouwer-Visser, PhD^1*, Nathalie Fiaschi, PhD^1*, Raquel P. Deering, PhD^1*, Ankur Dhanik, PhD^1*, Kamil J. Cygan, PhD^1*, Wen Zhang, PhD^1*, Se Jeong, MPH^1*, Stephane Pourpe, MS^1*, Lauren Boucher^1*, Sara Hamon, PhD^1*, Max S. Topp, MD², Rajat Bannerji, MD, PhD³, Johannes Duell, MD^2*, Ranjana Advani, MD⁴, Dina M. Flink, PhD^1*, Aafia Chaudhry, MD, MBA, MS^1*, Andres Sirulnik, MD, PhD¹, Andrew J. Murphy, PhD^1*, David M. Weinreich, MD^1*, George D. Yancopoulos, MD, PhD^1*, Gavin Thurston, PhD^1*, Srikanth R. Ambati, MBBS, MD^1* and Vladimir Jankovic, MD¹

¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²Universitätsklinikum Würzburg, Würzburg, Germany
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Stanford University, Stanford, CA

Erlene K. Seymour, MD¹, Yiwei Li^2*, Amro Aboukameel^2*, Radhakrishnan Ramchandren³, Golbon Sterbis^2*, Jay Yang, MD⁴, Divaya Bhutani, MD⁵, Ramzi Mohammad, PhD^6*, Asfar Sohail Azmi, PhD^6* and Jeff Zonder, MD⁷

¹Karmanos Cancer Institute, Wayne State University, Detroit, MI
²Department of Oncology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, MI
³University of Tennessee, Knoxville, TN
⁴Karmanos Cancer Institute, Detroit, MI
⁵Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Jersey City, NJ
⁶Department of Oncology, Karmanos Cancer Institute Wayne State University, Detroit, MI
⁷Karmanos Cancer Institute/Wayne State University, Detroit, MI

Mark Roschewski, MD¹, Christopher Melani, MD², Rahul Lakhotia, MD³, Stefania Pittaluga, MD, PhD⁴, James D. Phelan, PhD^3*, Cody Peer, PhD^5*, Michail S. Lionakis, MD, ScD^6*, Lydia L. Chou, CRNP^3*, Matthias Holdhoff, MD, PhD^7*, Michael Glantz, MD, PhD^8*, Jan Drappatz, MD^9*, Catherine Lai, MD, MPH¹⁰, John A. Butman, MD, PhD^11*, Andrea Nicole Lucas, RN^3*, Seth M. Steinberg, PhD^12*, William D. Figg, PhD^13*, Elaine S. Jaffe, MD⁴, S. Percy Ivy, MD^14*, Richard F. Little, MD, MPH¹⁵, Louis M. Staudt, MD, PhD³ and Wyndham H. Wilson, MD, PhD³

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Baltimore, MD
³Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁶Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁷Department of Neuro-Oncology, Johns Hopkins Cancer Center, Baltimore, MD
⁸Department of Neurosurgery, Penn State College of Medicine, Hershey, PA
⁹University of Pittsburgh, Pittsburgh, PA
¹⁰Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
¹¹Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹²Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹³Molecular Pharmacology Section, Genitourinary Malignancies Section, National Cancer Institute, Bethesda, MD
¹⁴National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
¹⁵Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD

Stephen D. Smith, MD^1,2, Jonathan R. Fromm, MD, PhD³, Min Fang, MD, PhD¹, Brian G. Till, MD¹, Mazyar Shadman, MD⁴, Ryan C. Lynch, MD^2,5, Andrew J. Cowan, M.D.^1,6, Qian Vicky Wu, PhD^7*, Jenna Voutsinas, MPH^8*, Heather A. Rasmussen, BS^9*, Katie Blue^10*, Chaitra S. Ujjani, MD^2,5, Andrei R Shustov, MD^1,2, Ryan D. Cassaday, MD^1,6 and Ajay K. Gopal, MD^2,5

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²University of Washington, Seattle, WA
³Department of Laboratory Medicine, University of Washington, Seattle, WA
⁴Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Department of Medicine, University of Washington, Seattle, WA
⁷Fred Hutchinson Cancer Research Center, Department of Clinical Biostatistics, Seattle, WA
⁸Fred Hutchinson Cancer Research Center, Seattle
⁹University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA

Nancy L. Bartlett, MD^1*, Christopher A. Yasenchak, MD², Robert B. Sims, MD³ and Grzegorz S. Nowakowski, MD⁴

¹Washington University School of Medicine Siteman Cancer Center, St. Louis, MO
²US Oncology, Eugene, OR
³Seattle Genetics, Inc., Bothell, WA
⁴Mayo Clinic, Rochester, MN

Luke Coyle, MBBS, FRACP, FRCPA^1*, Nicholas J. Morley^2*, Alessandro Rambaldi, MD³, Kylie D. Mason, MBBS, MD, FRACP, FRCPA, PhD⁴, Gregor Verhoef, MD, PhD^5*, Caroline Furness^6*, Rajendra Desai^7* and Noemi Mergen, MD^8*

¹Haematology, Royal North Shore Hospital, Sydney, Australia
²Haematology department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
³Department of Oncology and Hematology University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁴Department of Medicine, University of Melbourne, Melbourne, Australia
⁵Department of Hematology, University Hospitals Leuven, Leuven, Belgium
⁶Department of Paediatric Haemato-Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom
⁷Biostatistical Science, IQVIA Inc, Mumbai, India
⁸Amgen Research (Munich), Munich, Germany

Neil L Berinstein, MD¹, Isabelle Bence-Bruckler, MD^2*, Nicholas Allen Forward, MD, MSc, FRCPC³, Pierre Laneuville, MD, FRCPC⁴, Joy Mangel, MD, FRCPC⁵, Douglas A. Stewart, MD, FRCPC⁶, Irina Amitai, MD^7*, Gail Klein, MSc^8*, Nancy Pennell, BSc^9*, Iran Rashedi, MD, MSc^10*, Kim Roos, BA, BSc^8*, Yogesh Bramhecha^11* and Rebekah Conlon, RN^11*

¹Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, CAN
²Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
³Hematology, Nova Scotia Health Authority/ Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁴Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
⁵Department of Medicine, Division of Hematology, Western University, London Health Sciences Centre, London, ON, Canada
⁶Department of Oncology, University of Calgary/Tom Baker Cancer Centre, Calgary, AB, Canada
⁷Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada
⁸Centre for Clinical Trial Support, Sunnybrook Research Institute, Toronto, ON, Canada
⁹Biological Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada
¹⁰Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, CAN
¹¹IMV Inc., Dartmouth, NS, Canada